Amid efforts in Germany to retool the country’s drug spending, the U.S. | Amid efforts in Germany to retool the country’s drug spending, the U.S. is launching an investigation into what the Office of the United States Trade Representatives has branded “persistent underpayment” by the European nation for new meds.
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
US government launches probe into Germany's plan to pay less for drugs
US steps up pressure on Berlin over drug prices
U.S. opens tariff probe targeting Germany’s drug pricing policies
US probes Germany's 'persistent underpayment' for drugs
US opens trade probe into German drug pricing, escalating pressure on Europe | Euractiv
US launches trade probe into Germany over medicine prices
US launches Section 301 probe of Germany over pharmaceutical pricing
US launches trade probe on Germany over pharma pricing
US launches Germany pharma pricing probe, raising threat of new tariffs
US launches trade investigation into Germany over drug pricing
Following much opposition from drugmakers, Germany has scrapped its plan to install a program that would have reduced the price…
Germany’s new healthcare reform initiative has already led two global drugmakers to slice their planned investments in the…
In the U.S., many top brand-name drugs continue to get more expensive with age, while the same medicines often get cheaper in…
The US has opened a Section 301 investigation into Germany's drug pricing system, escalating trade pressure as Berlin reviews…
Washington accuses Berlin of underpaying for innovative medicines. If the investigation confirms this, the United States could…
Amid multiple efforts to rein in steep drug costs in the U.S., Colorado has received the all-clear to take matters into its own…
